Mesoblast Stock Price Prediction

MESO Stock  USD 18.82  0.14  0.75%   
As of today, The RSI of Mesoblast's share price is at 50. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Mesoblast, making its price go up or down.

Momentum 50

 Impartial

 
Oversold
 
Overbought
The successful prediction of Mesoblast's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Mesoblast, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Mesoblast's stock price prediction:
EPS Estimate Next Quarter
(0.14)
EPS Estimate Current Year
(0.28)
EPS Estimate Next Year
0.08
Wall Street Target Price
35
EPS Estimate Current Quarter
(0.25)
Using Mesoblast hype-based prediction, you can estimate the value of Mesoblast from the perspective of Mesoblast response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Mesoblast using Mesoblast's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Mesoblast using crowd psychology based on the activity and movement of Mesoblast's stock price.

Mesoblast Short Interest

An investor who is long Mesoblast may also wish to track short interest. As short interest increases, investors should be becoming more worried about Mesoblast and may potentially protect profits, hedge Mesoblast with its derivative instruments, or be ready for some potential downside.
200 Day MA
14.1883
Short Percent
0.0256
Short Ratio
10.06
Shares Short Prior Month
2.5 M
50 Day MA
16.4838

Mesoblast Hype to Price Pattern

Investor biases related to Mesoblast's public news can be used to forecast risks associated with an investment in Mesoblast. The trend in average sentiment can be used to explain how an investor holding Mesoblast can time the market purely based on public headlines and social activities around Mesoblast. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Mesoblast's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Mesoblast.

Mesoblast Implied Volatility

    
  1.1  
Mesoblast's implied volatility exposes the market's sentiment of Mesoblast stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Mesoblast's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Mesoblast stock will not fluctuate a lot when Mesoblast's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Mesoblast to buy its stock at a price that has no basis in reality. In that case, they are not buying Mesoblast because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Mesoblast after-hype prediction price

    
  USD 18.85  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Mesoblast contract

Based on the Rule 16, the options market is currently suggesting that Mesoblast will have an average daily up or down price movement of about 0.0688% per day over the life of the 2026-04-17 option contract. With Mesoblast trading at USD 18.82, that is roughly USD 0.0129 . If you think that the market is fully incorporating Mesoblast's daily price movement you should consider acquiring Mesoblast options at the current volatility level of 1.1%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Mesoblast Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mesoblast's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
16.9422.4925.82
Details
Naive
Forecast
LowNextHigh
15.7619.0922.42
Details
3 Analysts
Consensus
LowTargetHigh
31.8535.0038.85
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.00-0.360.00
Details

Mesoblast After-Hype Price Density Analysis

As far as predicting the price of Mesoblast at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mesoblast or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mesoblast, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Mesoblast Estimiated After-Hype Price Volatility

In the context of predicting Mesoblast's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mesoblast's historical news coverage. Mesoblast's after-hype downside and upside margins for the prediction period are 15.52 and 22.18, respectively. We have considered Mesoblast's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
18.82
18.85
After-hype Price
22.18
Upside
Mesoblast is not too volatile at this time. Analysis and calculation of next after-hype price of Mesoblast is based on 3 months time horizon.

Mesoblast Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Mesoblast is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mesoblast backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mesoblast, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.28 
3.33
  0.03 
  0.09 
9 Events / Month
7 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
18.82
18.85
0.16 
3,330  
Notes

Mesoblast Hype Timeline

Mesoblast is now traded for 18.82. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of -0.09. Mesoblast is projected to increase in value after the next headline, with the price projected to jump to 18.85 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.16%, whereas the daily expected return is now at 0.28%. The volatility of related hype on Mesoblast is about 1034.16%, with the expected price after the next announcement by competition of 18.73. The company reported the previous year's revenue of 17.2 M. Net Loss for the year was (102.14 M) with loss before overhead, payroll, taxes, and interest of (22.74 M). Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Mesoblast Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.

Mesoblast Related Hype Analysis

Having access to credible news sources related to Mesoblast's direct competition is more important than ever and may enhance your ability to predict Mesoblast's future price movements. Getting to know how Mesoblast's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mesoblast may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
OCULOcular Therapeutix 0.09 9 per month 0.00 (0.02) 6.04 (4.80) 35.70 
EWTXEdgewise Therapeutics 0.27 14 per month 4.14  0.16  14.33 (5.57) 38.85 
GLPGGalapagos NV ADR 0.11 38 per month 1.24  0.05  2.62 (2.52) 7.08 
GPCRStructure Therapeutics American(5.38)10 per month 2.78  0.18  8.96 (5.94) 110.34 
QUREUniqure NV 0.47 10 per month 0.00 (0.13) 9.37 (10.75) 60.67 
VRDNViridian Therapeutics 0.33 9 per month 1.88  0.15  5.57 (2.22) 15.86 
LQDALiquidia Technologies 0.99 9 per month 3.24  0.22  8.00 (4.84) 19.63 
NUVBNuvation Bio(0.36)9 per month 4.51  0.07  7.33 (5.78) 68.61 
IBRXImmunitybio(0.06)8 per month 4.12  0.20  11.16 (7.49) 51.87 
COGTCogent Biosciences 0.32 9 per month 2.38  0.13  5.94 (4.91) 126.24 

Mesoblast Additional Predictive Modules

Most predictive techniques to examine Mesoblast price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mesoblast using various technical indicators. When you analyze Mesoblast charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Mesoblast Predictive Indicators

The successful prediction of Mesoblast stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mesoblast, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mesoblast based on analysis of Mesoblast hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mesoblast's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mesoblast's related companies.
 2023 2024 2026 (projected)
Days Sales Outstanding1.3K315.51344.69
PTB Ratio1.372.092.28

Pair Trading with Mesoblast

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mesoblast position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will appreciate offsetting losses from the drop in the long position's value.

Moving together with Mesoblast Stock

  0.77VNDA Vanda PharmaceuticalsPairCorr

Moving against Mesoblast Stock

  0.48DRMA Dermata Therapeutics TrendingPairCorr
  0.42AMRN Amarin PLCPairCorr
  0.4SLN Silence Therapeutics PLCPairCorr
  0.39FSTF First State FinancialPairCorr
The ability to find closely correlated positions to Mesoblast could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mesoblast when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mesoblast - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mesoblast to buy it.
The correlation of Mesoblast is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mesoblast moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mesoblast moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mesoblast can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Mesoblast Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.85)
Revenue Per Share
0.14
Quarterly Revenue Growth
4.586
Return On Assets
(0.05)
Return On Equity
(0.19)
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.